Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Mild Cognitive Impairment
NCT04765137Phase 2Recruiting
- Sponsor
- Johns Hopkins University
- Start
- May 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in Mild Cognitive Impairment (MCI), sponsored by Johns Hopkins University. Started May 2021; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
Mild Cognitive Impairment (MCI)
Beyond the preview
Go deeper on NCT04765137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04765137.